Ipamorelin
A selective, third-generation growth hormone secretagogue (GHS) and ghrelin receptor agonist. Ipamorelin demonstrates high GH selectivity with minimal effect on cortisol, prolactin, or ACTH levels — making it a precise research tool for isolated GH axis studies.
Research Use Only. Ipamorelin is sold exclusively for in vitro research and laboratory use by qualified scientists. Not for human consumption, veterinary use, or clinical administration.
Research Literature
Published Research
Ipamorelin is a selective GH secretagogue with minimal off-target endocrine effects, widely studied for isolated GH axis research.
Ipamorelin, the first selective growth hormone secretagogue
Key finding: First GHS shown to stimulate GH release without significant cortisol or prolactin elevation.
PubMed 9849822 ↗Ipamorelin and growth hormone release in animal models
Key finding: Consistent pulsatile GH release with high receptor selectivity confirmed in vivo.
PubMed 10605085 ↗Comparison of GH secretagogues in clinical research
Key finding: Ipamorelin demonstrates superior selectivity profile vs GHRP-2 and GHRP-6.
PubMed 11117953 ↗Same Category